INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
KR
Kapito RobertDirector, President
BLKBlackRock, Inc.
Grant or award
A—
5,127 sh
Jan 16, 2026Jan 21, 2026
Page 1694 of 2053
← PrevNext →
traded Jan 16, 2026
+5d
SEC Form 4

Evidence

15
BK
Blackwood Lindsay K.SVP, Gen Counsel & Secretary
ITGRInteger Holdings Corp
Grant or award
A—
2,720 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

15
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
3,841 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

15
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

15
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Option exercise
M—
1,367 sh
Jan 18, 2026Jan 21, 2026
traded Jan 18, 2026
+3dSEC Form 4

Evidence

15
BA
Brooke Beth A.Director
NYTNEW YORK TIMES CO
Grant or award
A—
48 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

15
WS
Wagner SusanDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

15
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
4,884 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

13
HJ
Heitz Michael JohnChief Financial Officer
PRSUPursuit Attractions & Hospitality, Inc.
Tax withholding
F$21K
636 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

13
SB
Sanden BlayneSVP & PAO
WAFDWAFD INC
Grant or award
A$24K
750 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

13
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$337K
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

13
WS
Wagner ScottDirector
GDRXGoodRx Holdings, Inc.
Option exercise
M—
31.4K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

12
ON
Olmstead NathanSVP and CFO
PENGPenguin Solutions, Inc.
Tax withholding
F$60K
2,988 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
SD
Smith DironEVP, Chief Financial Officer
ITGRInteger Holdings Corp
Tax withholding
F$73K
848 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

12
BT
Baur Frank TobiasEVP, Chief Operating Officer
DBDDIEBOLD NIXDORF, Inc
Tax withholding
F$50K
716 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

12
MO
Marquez OctavioDirector, President and CEO
DBDDIEBOLD NIXDORF, Inc
Tax withholding
F$219K
3,136 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

12
RC
Radigan Elizabeth ChristineEVP, Chief Administrative Ofcr
DBDDIEBOLD NIXDORF, Inc
Tax withholding
F$53K
757 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

12
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Tax withholding
F$67K
3,379 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$23K
396 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

12
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Tax withholding
F$51K
2,564 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

12
MJ
Myers JonathanEVP, Chief Revenue Officer
DBDDIEBOLD NIXDORF, Inc
Tax withholding
F$73K
1,047 sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence

11
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
SD
Smith DironEVP, Chief Financial Officer
ITGRInteger Holdings Corp
Grant or award
A—
7,091 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
IK
Issa Mohamed KhairieEVP, Head of US Oncology
INCYINCYTE CORP
Grant or award
A—
14.2K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
TT
Tray ThomasPrincipal Accounting Officer
INCYINCYTE CORP
Grant or award
A—
2,425 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
CB
Cree BrianPresident
VTSVitesse Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
1,440 sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

11
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
9,067 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

11
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Option exercise
M—
27.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
MA
Mayes Patrick AEVP & Chief Scientific Officer
INCYINCYTE CORP
Grant or award
A—
4,218 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

10
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Derivative conversion · 10b5-1 plan
C—
6.60M sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

10
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

9
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Grant or award
A—
10.2K sh
Jan 19, 2026Jan 21, 2026
traded Jan 19, 2026
+2dSEC Form 4

Evidence